Ono Pharma Foundation
Ono Pharma Foundation

Ono Pharma Foundation was developed by Ono Pharmaceutical Co. Ltd. to support Principal Investigators with discovering to new therapeutic approaches.

Ono Pharmaceutical Co., Ltd. is a leading global healthcare company committed to delivering new, innovative drugs to patients, and championing the fight against disease and pain, together with researchers, patients, their families, and healthcare providers.

Our Story


DEDICATED TO MAN'S FIGHT AGAINST DISEASE AND PAIN

In 1717 in Dosho-machi, Osaka that Ichibei Fushimiya first opened his apothecary. Through its 300-year history, Ono Pharmaceutical Co. has been dedicated to developing innovative and breakthrough pharmaceutical products.

Mission


The purpose of the Ono Initiative is to support scientist Principal Investigators (“PIs”) with creative ideas in selected scientific research fields with the mission of seeking discoveries/solutions and development of high impact science. The goals of the Ono Initiative are:

Supporting Innovation

SUPPORTING
INNOVATION

Identify and help develop innovative research proposals and results that could lead to the development of breakthrough treatment solutions for patients.

Promoting Scientists

PROMOTING
SCIENTISTS

Support academic research and the career development of promising young and established scientists.

Building Relationships

BUILDING
RELATIONSHIPS

Build strong relationships within the community in order to lead to transformative research aligned with Ono Initiative's interest.

Foundation Board and Officers


Our board is responsible for appointing members to the Scientific Advisory Board. Learn more about our Foundation Board.

Tetsuya Sugiyama, Ph.D.

Tetsuya Sugiyama, Ph.D.

Director, President

Hiroshi Ochiai, Ph.D.

Hiroshi Ochiai, Ph.D.

Vice President

Soichi Kawaharada

Soichi Kawaharada

Secretary

Shingo Hotta, Ph.D.

Shingo Hotta, Ph.D.

Treasurer

Scientific Advisory Board


Stuart L. Schreiber, Ph.D.

Chair of the Scientific Advisory Board


David Corey, Ph.D.


Benjamin Cravatt, Ph.D.


Carolyn R. Bertozzi, Ph.D.


Masad J. Damha, Ph.D., F.C.I.C.